Picture of GeneDx Holdings logo

WGS — GeneDx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Sema4 Holdings Corp reports results for the quarter ended in September - Earnings Summary

* Sema4 Holdings Corp  SMFR.OQ  reported a quarterly
adjusted loss
of 20 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 21 cents per share.
    * Revenue rose 92.8% to $83.23 million from a year ago;
analysts
expected $71.67 million. 
    * Sema4 Holdings Corp's reported EPS for the quarter was a
loss
of 20 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sema4 Holdings Corp shares had risen by 16.2% this
quarter and
lost 77.1% so far this year.
    * The company reported a quarterly loss of $77.58 million.
    * Wall Street's median 12-month price target for Sema4
Holdings
Corp is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 05:08 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.21          -0.20          Beat
 Jun. 30 2022      -0.21          -0.25          Missed
 Mar. 31 2022      -0.31          -0.31          Met
 Dec. 31 2021      -0.26          -0.17          Beat

Recent news on GeneDx Holdings

See all news